Quote:esmo i see as a speed bump on the way to ASCO-GI tbh.
You don't mean a speed bump, which is essentially an obstacle, slowing us down. ESMO will provide certainly valuable ctDNA and PD-L1 data, as HighTechGuru notes. For the value of the stock, PD-L1 is truly critical. If Leron elevates it, a partnership or buyout is inevitable. So to continue your vehicular metaphor, how about ESMO as a ramp up to ASCO. Then we can stick the landing.